doi: 10.3967/bes2018.044
Decrease in Serum Amyloid a Protein Levels Following Three-month Stays in Negatively Charged Particle-dominant Indoor Air Conditions
-
Abstract:
Objective The changes in serum adipokines and cytokines related to oxidative stress were examined during 3 months 'Off to On' and 'On to Off' periods using negatively charged particle-dominant indoor air conditions (NCPDIAC). Methods Seven volunteers participated in the study, which included 'OFF to 3 months ON' periods (ON trials) for a total of 16 times, and 'ON to 3 months OFF' (OFF trials) periods for a total of 13 times. Results With the exception of one case, serum amyloid A (SAA) levels decreased significantly during the ON trials. Conclusion Considering that SAA is an acute phase reactive protein such as C reactive protein (CRP), this observed decrease might indicate the prevention of cardiovascular and atherosclerotic changes, since an increase in high-sensitive CRP is associated with the subsequent detection of these events. -
Key words:
- Negatively charged particle /
- Indoor air /
- Serum amyloid A /
- Biomarker /
- Cardiovascular disease
-
Figure 1. Changes in actual measured values, relative changes in actual measured values (pre-value as 1.0), logarithmic converted values of actual values, and relative changes in values of ON trials observed for resistin (A) and IL-8 (B). For both cytokines, the relative changes in actual measured values tended to increase (0.5 < P < 1.0), although other analyses revealed no statistical significance or tendencies.
Figure 2. Changes in actual measured values, relative changes in actual measured values (pre-value as 1.0), logarithmic converted values of actual values, and relative changes in values of ON trials observed for SAA (A), and SAA with one case omitted, which showed an exceptionally marked increase (B). In all 16 ON trials, logarithmic converted actual values showed a tendency to decrease, and logarithmic converted relative changes showed a significant decrease in SAA levels (A). Additionally, with the omission of one case that showed an exceptionally marked increase in SAA, all other cases revealed a significant decrease in SAA (B).
Supplemental Figure 1. Summary of construction, short-term (2.5 h)[15] and mid-term (two weeks, nightly stays) experiments[16] with negatively charged particle-dominant indoor air conditions (NCPDIAC) and in vitro experimental approaches[17]. (A) The construction of NCPDIAC was performed by initially painting fine charcoal powder onto the walls and ceiling of a room[15]. The charcoal coating designated as Health Coat was produced by Artech Kohbou Co. Ltd. The NCPDIAC device was then completed by applying an electric voltage (72 V) between the backside of the walls and the ground[15]. This device generates a slight negative charge at the surface of the wall, which facilitates the adsorption of positively charged particles[15]. Thus, the presence of negatively charged particles predominates and is continuous (particles approximately 20 nm in diameter, and 500 particles per 1 cc of air volume)[15]. (B) The short-term (2.5 h) stay experiments comprising 60 volunteers, with each occupying a control or experimental (NCPDIAC) room, showed slight but significant increases in IL-2 after a 2.5 h stay with NCPDIAC[16]. (C) The mid-term (two weeks, nightly stays) experiments comprising 15 volunteers showed enhanced natural killer (NK) cell activity[16]. Volunteers initially occupied control rooms and thereafter moved to NCPDIAC rooms without being informed of the type of room they were occupying[16]. Differences in various biological markers were then analyzed between pre- and post-NCPDIAC stays[16]. Only a significant increase in NK cell activity was found[16]. (D) Taken together, it was speculated that even though a short-term increase in IL-2 did not affect NK cell activity, recurrent and repeated accumulation of IL-2 for two weeks would result in a gradual enhancement of NK cell activity[16]. (E) The experimental assays were performed using peripheral blood mononuclear cells (PBMCs) from healthy volunteers, comparing changes in immune cells between exposure to a standard incubator and an NCPDIAC-resembling incubator (NC incubator; negatively charged particles were continuously forced into and out of the incubator, with negatively charged particles being predominant and accounting for approximately 3, 000 particles per 1 cc)[17]. As a result, it was found that CD25 expression in CD4+ T cells, IFNγ production in PBMC cultures, and NK cell activity were enhanced. The Immune Index also increased with the use of the NC incubator[17].
Supplemental Figure 2. Long-term (three-month) stays with negatively charged particle-dominant indoor air conditions (NCPDIAC) were performed by employing the NCPDIAC device in actual living homes of seven volunteers[18]. (A) The NCPDIAC device was installed in each home and volunteers switched the device ON or OFF every three months[18]. (B) Various biomarkers were examined every three months. A total of 16 'OFF to three months ON' (ON trials) and 13 'ON to three months OFF' (OFF trials) experiments were performed with seven volunteers[18]. (C) Significant changes were only found in NK cell activity. The ON and OFF trials showed enhanced and reduced NK cell activity, respectively, with an NK cell to target cell ratio of 10:1 or 20:1. (D) The aim of this study was to examine the changes in adipokines and cytokines related to oxidative stress using samples from this long-term experiment[18].
-
[1] Redlich CA, Sparer J, Cullen MR. Sick-building syndrome. Lancet, 1997; 349, 1013-6 doi: 10.1016/S0140-6736(96)07220-0 [2] Menzies D, Bourbeau J. Building-related illnesses. N Engl J Med, 1997; 337, 1524-31. doi: 10.1056/NEJM199711203372107 [3] Hodgson M. Sick building syndrome. Occup Med, 2000; 15, 571-85. [4] Norbäck D, Edling C. Environmental, occupational, and personal factors related to the prevalence of sick building syndrome in the general population. Br J Ind Med, 1991; 48, 451-62. http://europepmc.org/abstract/MED/1854648 [5] Matsuzaka Y, Ohkubo T, Kikuti YY, et al. Association of sick building syndrome with neuropathy target esterase (NTE) activity in Japanese. Environ Toxicol, 2014; 29, 1217-26. doi: 10.1002/tox.v29.10 [6] Matsuzaka Y, Kikuti YY, Mizutani A, et al. Association study between sick building syndrome and polymorphisms of seven human detoxification genes in the Japanese. Environ Toxicol Pharmacol, 2010; 29, 190-4. doi: 10.1016/j.etap.2009.11.007 [7] Norbäck D. An update on sick building syndrome. Curr Opin Allergy Clin Immunol, 2009; 9, 55-9. doi: 10.1097/ACI.0b013e32831f8f08 [8] Burge PS. Sick building syndrome. Occup Environ Med, 2004; 61, 185-90. doi: 10.1136/oem.2003.008813 [9] Straus DC. Molds, mycotoxins, and sick building syndrome. Toxicol Ind Health, 2009; 25, 617-35. doi: 10.1177/0748233709348287 [10] Jacobs RL, Andrews CP, Coalson JJ. Hypersensitivity pneumonitis:beyond classic occupational disease-changing concepts of diagnosis and management. Ann Allergy Asthma Immunol, 2005; 95, 115-28. doi: 10.1016/S1081-1206(10)61200-8 [11] Patel AM, Ryu JH, Reed CE. Hypersensitivity pneumonitis:current concepts and future questions. J Allergy Clin Immunol, 2001; 108, 661-70. doi: 10.1067/mai.2001.119570 [12] Obayashi K, Saeki K, Kurumatani N. Independent Associations Between Nocturia and Nighttime Blood Pressure/Dipping in Elderly Individuals:The HEIJO-KYO Cohort. J Am Geriatr Soc, 2015; 63, 733-8. doi: 10.1111/jgs.2015.63.issue-4 [13] Saeki K, Obayashi K, Tone N, et al. A warmer indoor environment in the evening and shorter sleep onset latency in winter:The HEIJO-KYO study. Physiol Behav, 2015; 149, 29-34. doi: 10.1016/j.physbeh.2015.05.022 [14] Saeki K, Obayashi K, Tone N, et al. Daytime cold exposure and salt intake based on nocturnal urinary sodium excretion:A cross-sectional analysis of the HEIJO-KYO study. Physiol Behav, 2015; 152, 300-6. doi: 10.1016/j.physbeh.2015.10.015 [15] Takahashi K, Otsuki T, Mase A, et al. Negatively-charged air conditions and responses of the human psycho-neuroendocrino-immune network. Environ Int, 2008; 34, 765-72. doi: 10.1016/j.envint.2008.01.003 [16] Takahashi K, Otsuki T, Mase A, et al. Two weeks of permanence in negatively-charged air conditions causes alteration of natural killer cell function. Int J Immunopathol Pharmacol, 2009; 22, 333-42. doi: 10.1177/039463200902200210 [17] Nishimura Y, Takahashi K, Mase A, et al. Exposure to negatively charged-particle dominant air-conditions on human lymphocytes in vitro activates immunological responses. Immunobiology, 2015; 220, 1359-68. doi: 10.1016/j.imbio.2015.07.006 [18] Nishimura Y, Takahashi K, Mase A, et al. Enhancement of NK Cell Cytotoxicity Induced by Long-Term Living in Negatively Charged-Particle Dominant Indoor Air-Conditions. PLoS One, 2015; 10, e0132373. doi: 10.1371/journal.pone.0132373 [19] Wolf G. Insulin resistance and obesity:resistin, a hormone secreted by adipose tissue. Nutr Rev, 2004; 62, 389-94. doi: 10.1111/nure.2004.62.issue-10 [20] Haluzik M, Haluzikova D. The role of resistin in obesity-induced insulin resistance. Curr Opin Investig Drugs, 2006; 7, 306-11. https://www.researchgate.net/publication/7154333_The_role_of_resistin_in_obesity-induced_insulin_resistance [21] Filková M, Haluzík M, Gay S, et al. The role of resistin as a regulator of inflammation:Implications for various human pathologies. Clin Immunol, 2009; 133, 157-70. doi: 10.1016/j.clim.2009.07.013 [22] Baggiolini M, Clark-Lewis I. Interleukin-8, a chemotactic and inflammatory cytokine. FEBS Lett, 1992; 307, 97-101. doi: 10.1016/0014-5793(92)80909-Z [23] Kunkel SL, Lukacs NW, Strieter RM. The role of interleukin-8 in the infectious process. Ann N Y Acad Sci, 1994; 730, 134-43. doi: 10.1111/nyas.1994.730.issue-1 [24] Roebuck KA. Oxidant stress regulation of IL-8 and ICAM-1 gene expression:differential activation and binding of the transcription factors AP-1 and NF-κB. Int J Mol Med, 1999; 4, 223-30. http://www.ncbi.nlm.nih.gov/pubmed/10425270 [25] Jain SK, Rains J, Croad J, et al. Curcumin supplementation lowers TNF-alpha, IL-6, IL-8, and MCP-1 secretion in high glucose-treated cultured monocytes and blood levels of TNF-alpha, IL-6, MCP-1, glucose, and glycosylated hemoglobin in diabetic rats. Antioxid Redox Signal, 2009; 11, 241-9. doi: 10.1089/ars.2008.2140 [26] Ivison SM, Wang C, Himmel ME, et al. Oxidative stress enhances IL-8 and inhibits CCL20 production from intestinal epithelial cells in response to bacterial flagellin. Am J Physiol Gastrointest Liver Physiol, 2010; 299, G733-41. doi: 10.1152/ajpgi.00089.2010 [27] Paszti-Gere E, Csibrik-Nemeth E, Szeker K, et al. Acute oxidative stress affects IL-8 and TNF-α expression in IPEC-J2 porcine epithelial cells. Inflammation, 2012; 35, 994-1004. doi: 10.1007/s10753-011-9403-8 [28] Benditt EP, Hoffman JS, Eriksen N, et al. SAA, an apoprotein of HDL:its structure and function. Ann N Y Acad Sci, 1982; 389, 183-9. doi: 10.1111/nyas.1982.389.issue-1 [29] Salazar A, Pintó X, Mañá J. Serum amyloid A and high-density lipoprotein cholesterol:serum markers of inflammation in sarcoidosis and other systemic disorders. Eur J Clin Invest, 2001; 31, 1070-7. doi: 10.1046/j.1365-2362.2001.00913.x [30] Hua S, Song C, Geczy CL, et al. A role for acute-phase serum amyloid A and high-density lipoprotein in oxidative stress, endothelial dysfunction and atherosclerosis. Redox Rep, 2009; 14, 187-96. doi: 10.1179/135100009X12525712409490 [31] Malle E, Steinmetz A, Raynes JG. Serum amyloid A (SAA):an acute phase protein and apolipoprotein. Atherosclerosis, 1993; 102, 131-46. doi: 10.1016/0021-9150(93)90155-N [32] Marhaug G, Dowton SB. Serum amyloid A:an acute phase apolipoprotein and precursor of AA amyloid. Baillieres Clin Rheumatol, 1994; 8, 553-73. doi: 10.1016/S0950-3579(05)80115-3 [33] Malle E, De Beer FC. Human serum amyloid A (SAA) protein:a prominent acute-phase reactant for clinical practice. Eur J Clin Invest, 1996; 26, 427-35. doi: 10.1046/j.1365-2362.1996.159291.x [34] Willcox BJ, Abbott RD, Yano K, et al. C-reactive protein, cardiovascular disease and stroke:new roles for an old biomarker. Expert Rev Neurother, 2004; 4, 507-18. doi: 10.1586/14737175.4.3.507 [35] Di Napoli M, Schwaninger M, Cappelli R, et al. Evaluation of C-reactive protein measurement for assessing the risk and prognosis in ischemic stroke:a statement for health care professionals from the CRP Pooling Project members. Stroke, 2005; 36, 1316-29. doi: 10.1161/01.STR.0000165929.78756.ed [36] Clearfield MB. C-reactive protein:a new risk assessment tool for cardiovascular disease. J Am Osteopath Assoc, 2005; 105, 409-16. http://www.citeulike.org/group/982/article/697790 [37] Yeh ET. High-sensitivity C-reactive protein as a risk assessment tool for cardiovascular disease. Clin Cardiol, 2005; 28, 408-12. doi: 10.1002/clc.v28:9